Search Results - "Thoreau, Etienne"
-
1
Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne
Published in Journal of medicinal chemistry (10-05-2018)“…The use of an interleukin β antibody is currently being investigated in the clinic for the treatment of acne, a dermatological disorder affecting 650M persons…”
Get full text
Journal Article -
2
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma
Published in Bioorganic & medicinal chemistry letters (15-09-2018)“…[Display omitted] •A novel squaramide-based scaffold for HDAC inhibition is proposed.•Inhibitors are optimized for topical route of administration.•Aqueous and…”
Get full text
Journal Article -
3
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne
Published in Bioorganic & medicinal chemistry letters (01-06-2018)“…[Display omitted] •X-ray of known RARγ-agonist CD437- RARγ complex was obtained.•Hypothesis for the isotype selectivity of known RARγ-agonist CD437 are…”
Get full text
Journal Article -
4
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists
Published in Bioorganic & medicinal chemistry letters (01-12-2016)“…[Display omitted] Targeting the IL17 pathway and more specifically the nuclear receptor RORγ is thought to be beneficial in multiple skin disorders. The Letter…”
Get full text
Journal Article -
5
New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space
Published in Bioorganic & medicinal chemistry letters (15-12-2017)“…[Display omitted] Virtual fragmentation of a library of 12,000 compounds inspired by natural products led to a dataset of 153,000 fragments that was used as a…”
Get full text
Journal Article -
6
Sulfoximines as potent RORγ inverse agonists
Published in Bioorganic & medicinal chemistry letters (01-05-2018)“…Compound 4a CD4 IL-17 IC50 = 17 nM. [Display omitted] Progress in the identification of suitable RORγ inverse agonists as clinical candidates has been hampered…”
Get full text
Journal Article -
7
Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors
Published in ACS medicinal chemistry letters (14-11-2019)“…Minor structural modificationssometimes single atom changescan have a dramatic impact on the properties of compounds. This is illustrated here on structures…”
Get full text
Journal Article -
8
Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis
Published in ChemMedChem (20-02-2018)“…With possible implications in multiple autoimmune diseases, the retinoic acid receptor‐related orphan receptor RORγ has become a sought‐after target in the…”
Get full text
Journal Article -
9
A genetic algorithm for the automated generation of small organic molecules: drug design using an evolutionary algorithm
Published in Journal of computer-aided molecular design (01-07-2000)“…Rational drug design involves finding solutions to large combinatorial problems for which an exhaustive search is impractical. Genetic algorithms provide a…”
Get full text
Journal Article -
10
-
11
A Genetic Algorithm for the Automated Generation of Small Organic Molecules
Published in Journal of computer-aided molecular design (01-07-2000)Get full text
Journal Article -
12
Quantitative structure-activity relationship studies of RAR α, β, γ retinoid agonists
Published in Quantitative structure-activity relationships (01-06-1999)“…Structure‐Activity Relationships have been established for 140 synthetic retinoid agonists. Retinoids, natural and synthetic analogues of vitamin A, are…”
Get full text
Journal Article